Summarized by Masters of Longevity from Science Daily - Health & Medicine.
New research reveals an unexpected non-enzymatic role for NUDT5 that alters cellular response to a long‑used leukemia chemotherapy agent.
Key Takeaways
- Materials provided by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences.
- A 70-year-old leukemia drug is still revealing new secrets.
- Researchers found that removing a protein called NUDT5 protected cells from the drug, even though simply blocking the protein had little effect.
